Court Approves Concordatum for Borsa Istanbul-Listed Turk Ilac ve Serum Sanayi A.S.

The concordato decision is a serious negative development indicating that the company is in financial difficulty and unable to pay its debts. Technical indicators already show a weak outlook; RSI is at 45, below the neutral zone, and MACD is below zero and weak despite being above the signal line. The price is trading below both the 20-day and 50-day moving averages. This news will further deteriorate the already weak technical structure and increase selling pressure. A significant decline in the stock can be expected in the short term.

Although SRM's RSI has approached the oversold region at 30.9, the price is trading below both its 20-day and 50-day moving averages. The MACD line remains below the signal line and in negative territory, confirming weak momentum. The 4% decline over the past 24 hours, coupled with news of a concordato (debt restructuring), suggests that selling pressure may persist in the short term. However, the oversold region and low price level also raise the possibility of a sudden rebound, so the bearish outlook can be expressed with medium-high confidence.